Read More Pharma Industry News LIPAC Oncology takes NMIBC treatment TBC-1002 into phase 2 A trial Investigational NMIBC treatment TBC-1002 : LIPAC Oncology said that it has wrapped up a phase 1 clinical trial… bypharmanewsdailyOctober 27, 2019
